
Release date: 2024-08-27 14:53:06 Article From: Lucius Laos Recommended: 327
As a PIK3CA kinase inhibitor, Alpelisib plays an important role in the relationship between the activation of the PI3K pathway and tumor drug resistance, especially in patients with HR/HER2- advanced breast cancer.
The use of Alpelisib may be accompanied by some side effects, and caution should be taken when using it.
Blood sugar levels may rise after taking medications, increasing the risk of diabetes or worsening pre-existing diabetes. Common symptoms of hyperglycemia include thirst, frequent urination, and weight loss.
Medications can affect kidney function, causing creatinine levels to rise. May be a sign of impaired renal filtration and require regular monitoring of kidney function.
If you experience any adverse reactions, please contact your doctor promptly. Especially for special populations, the use of drugs needs to be paid more attention.
If you experience any adverse reactions, please contact your doctor promptly. Especially for special populations, the use of drugs needs to be paid more attention.
The safety and efficacy of Alpelisib in children has not been established, and the use of the drug in pediatric patients is not recommended. Your doctor will evaluate whether there are other treatment options that are more appropriate on a case-by-case basis.
In severe renal impairment, the effects of Alpelisib are unknown; For patients with mild to moderate renal impairment, dose adjustment is usually not necessary. It is recommended to use it under the guidance of a physician for proper monitoring and adjustment according to the individual situation.
Special populations need to follow their doctor's advice when using medications. Patients should also pay attention to the precautions for the administration of the drug before purchasing and using the drug.
Here are some things to keep in mind when using Alpelisib.
Alpelisib can be harmful to the fetus, and women of childbearing potential should use effective contraception during treatment and for a week after the last dose. Condoms are used in men. It is advisable to be aware of the potential risks of the drug before treatment.
In case of severe hypersensitivity reactions (e.g., rash, dyspnea, or facial swelling), Alpelisib should be stopped immediately and permanently discontinued. Patients need to be aware of these symptoms and seek immediate medical attention if they occur.
Understanding these medication considerations can help patients navigate their treatment. Follow the advice and consult your doctor promptly if you feel unwell.
[Warm tips] Before purchasing and using drugs, patients should fully understand the relevant information of drugs and avoid blind medication.
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended:3492025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended:5512024-09-07
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved niraparib in combination ···【more】
Recommended:3362025-15-12
The U.S. Food and Drug Administration (FDA) announced today that it has approved Omisirge (omidubice···【more】
Recommended:3502025-10-12
On December 4, 2025, the U.S. Food and Drug Administration (FDA) approved lisocabtagene maraleucel (···【more】
Recommended:3262025-08-12
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full approval to pirtobruti···【more】
Recommended:3922025-04-12
Primary analysis data from the randomized, double-blind, placebo-controlled phase III HER2CLIMB-02 s···【more】
Recommended:3252025-01-12
The Cure SMA Foundation, a global leading non-profit organization dedicated to spinal muscular atrop···【more】
Recommended:3002025-27-11

Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com

Name: Lucius

Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643